Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Venous Thromboembolism in Cancer Patients”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableLooking for participantsNCT07372716
What this trial is testing

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Who this might be right for
ThrombosisCancerThrombosis, Deep Vein+3 more
Ottawa Hospital Research Institute 700
Large-scale testing (Phase 3)Ended earlyNCT02583191
What this trial is testing

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Who this might be right for
Venous ThromboembolismCancer
AIO-Studien-gGmbH 246
Not applicableStudy completedNCT02742623
What this trial is testing

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Who this might be right for
Venous Thrombosis and Pulmonary Embolism
Bayer 528
Not applicableStudy completedNCT05112666
What this trial is testing

Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer Patients
Bayer 2,601
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Not applicableUnknownNCT05229471
What this trial is testing

Management of Recurrent Venous Thromboembolism During Anticoagulant Treatment in Cancer Patients - a Prospective Cohort Study

Who this might be right for
CancerVenous ThromboembolismRecurrence
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 220
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableLooking for participantsNCT06950697
What this trial is testing

Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Lung CancerVenous ThromboembolismArterial Thromboembolism+1 more
Beijing Chao Yang Hospital 2,400
Not applicableStudy completedNCT01855698
What this trial is testing

PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism

Who this might be right for
Hematologic NeoplasmAcute LeukemiaMyelodysplastic Syndrome+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 99
Post-approval studies (Phase 4)Study completedNCT02958969
What this trial is testing

Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma

Who this might be right for
Venous ThromboembolismMultiple Myeloma
Gregory Piazza 50
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Testing effectiveness (Phase 2)Ended earlyNCT00981903
What this trial is testing

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous ThromboembolismCancer
University of Southern California 131
Large-scale testing (Phase 3)Study completedNCT05625932
What this trial is testing

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticThromboembolism
Galician Research Group on Digestive Tumors 232
Not applicableStudy completedNCT01362933
What this trial is testing

National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients

Who this might be right for
NeoplasmsVenous Thromboembolism
Floralis 502
Testing effectiveness (Phase 2)Study completedNCT00952380
What this trial is testing

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Who this might be right for
Venous Thromboembolism
Pfizer 38
Post-approval studies (Phase 4)Study completedNCT04072068
What this trial is testing

Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy

Who this might be right for
ThromboembolismCancer
Gruppo Oncologico Italiano di Ricerca Clinica 150
Large-scale testing (Phase 3)Not Yet RecruitingNCT07160686
What this trial is testing

Apixaban to Prevent Venous Thromboembolism in Ambulatory Lung Cancer Patients Undergoing Systemic Anticancer Treatment

Who this might be right for
Thromboprophylaxis
University of Birmingham 1,456
Not applicableStudy completedNCT01803022
What this trial is testing

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 419
Large-scale testing (Phase 3)Study completedNCT01130025
What this trial is testing

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 900
Not applicableStudy completedNCT05150938
What this trial is testing

Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer Patients
Bayer 5,737
Next Page